Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: J Immunol Methods. 2015 Apr 9;422:111–117. doi: 10.1016/j.jim.2015.04.001

Table 1. Characteristics of murine and chimeric mAbs used in this study.

mAb Speciesa Isotype Target Agglutination (μg/ml)b Vibriocidalc
2D6 mouse IgA O-PS 18 no
chimeric IgG1 nd yes
ZAC-3 mouse IgA Lipid A/core 0.25 no
chimeric IgG1 nd yes
a

Chimeric antibodies were composed of a murine variable region grafted onto a human IgG1 constant region.

b

Lowest antibody concentration that induced visible agglutination of V. cholerae O395 after 2 hr incubation at 37°C, nd: none detected.

c

Late exponential phase V. cholerae O395 was pre-mixed with guinea pig serum and incubated in LB media containing 100 μg/ml of antibody. Bacterial samples were diluted and plated for CFUs. Vibriocidal activity was defined as ≥1 log decrease in CFU compared to control treatment.